论文信息 - CTONG 1103: Erlotinib versus gemcitabine plus cisplatin as neo-adjuvant treatment for stage IIIA-N2 EGFR-mutation non-small cell lung cancer (EMERGING): A randomised study. - 字舞流文

CTONG 1103: Erlotinib versus gemcitabine plus cisplatin as neo-adjuvant treatment for stage IIIA-N2 EGFR-mutation non-small cell lung cancer (EMERGING): A randomised study.

Q. Wang | W. Zhong | Q. Zhou | J. Yang | Y. Wu | Y. Cheng | C. Gu | L. Xu | W. Mao | K-N Chen | C. Chen | J. Wang | G. Qiao | C-L Wang | M-W Chen | X-N. Yang | H-J. Chen | H-H Yang